Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Clara D. Bloomfield Charles A Schiffer Michael A Caligiuri Richard A. Larson |
| Publication date | September 1, 2002 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |